Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Laskin

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Lupus|November 14, 2014
Ovarian reserve in antiphospholipid syndrome: the jury is still outC A Clark, C A Laskin
Placenta|August 24, 1999
Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic reviewJ G Ray, C A Laskin
The Journal of Rheumatology|January 1, 1988
Anticardiolipin antibodies: smoking gun or smoke screen?C A Laskin, C A Solonínka
The Journal of Rheumatology|August 1, 1997
Sex hormones in systemic lupus erythematosus: a controversy for modern timesI N Bruce, C A Laskin
The Journal of Rheumatology|May 1, 2001
In vitro thrombin generationC A Clark-Soloninka, C A Laskin
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1986
The regulatory role of NZB T lymphocytes in the production of anti-DNA antibodies in vitroC A Laskin, G Haddad, C A Soloninka
The Journal of Rheumatology|September 12, 2001
The spectrum of the antiphospholipid syndrome: a matter of perspectiveC A Clark, K A Spitzer, C A Laskin
Arthritis and Rheumatism|March 17, 2004
Recurrent pregnancy loss in the context of antiphospholipid antibodies: comment on the article by Triolo et alC A Laskin, C A Clark, K A Spitzer
The Journal of Rheumatology|June 1, 1989
Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19C A Soloninka, M J Anderson, C A Laskin
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1982
The specificity of in vivo tolerance to haptens in NZB and normal mice after exposure to hapten-modified syngeneic spleen cellsJ S Cowdery, C A Laskin, A D Steinberg
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Lupus|November 14, 2014
Ovarian reserve in antiphospholipid syndrome: the jury is still outC A Clark, C A Laskin
Placenta|August 24, 1999
Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic reviewJ G Ray, C A Laskin
The Journal of Rheumatology|January 1, 1988
Anticardiolipin antibodies: smoking gun or smoke screen?C A Laskin, C A Solonínka
The Journal of Rheumatology|August 1, 1997
Sex hormones in systemic lupus erythematosus: a controversy for modern timesI N Bruce, C A Laskin
The Journal of Rheumatology|May 1, 2001
In vitro thrombin generationC A Clark-Soloninka, C A Laskin
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1986
The regulatory role of NZB T lymphocytes in the production of anti-DNA antibodies in vitroC A Laskin, G Haddad, C A Soloninka
The Journal of Rheumatology|September 12, 2001
The spectrum of the antiphospholipid syndrome: a matter of perspectiveC A Clark, K A Spitzer, C A Laskin
Arthritis and Rheumatism|March 17, 2004
Recurrent pregnancy loss in the context of antiphospholipid antibodies: comment on the article by Triolo et alC A Laskin, C A Clark, K A Spitzer
The Journal of Rheumatology|June 1, 1989
Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19C A Soloninka, M J Anderson, C A Laskin
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1982
The specificity of in vivo tolerance to haptens in NZB and normal mice after exposure to hapten-modified syngeneic spleen cellsJ S Cowdery, C A Laskin, A D Steinberg
Pageof 4